RTIX Financial Facts
Net income per common share - basic: -0.08Total other expense - net: -374K
See Full Income Statement
Total stockholders' equity: 178.34M
Accumulated other comprehensive income (loss): -6.9M
See Full Balance Sheet
RTI Biologics, Inc. (RTIX) Earnings
|
Expand Research on RTIX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +125.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/1/18 |  |
Q318 | $0.04 | $0.01 | +$0.03 | $69.1M | $68.64M | = |  | | Details |
| 8/2/18 | |
Q218 | $0.03 | $0.01 | +$0.02 | $70.7M | $70.19M | = | | | Details |
| 5/3/18 | |
Q118 | $0.01 | $0.01 | $0.00 | $69.9M | $68.73M | = | | | Details |
| 3/1/18 | |
Q417 | $0.03 | $0.03 | $0.00 | $70.8M | $69.7M | = | | | Details |
| 11/2/17 | |
Q317 | $0.01 | $0.01 | $0.00 | $66.7M | $65.38M | = | | | Details |
| 8/8/17 | |
Q217 | $0.02 | $0.02 | $0.00 | $72.1M | $69.89M | = | | | Details |
| 4/27/17 | |
Q117 | -$0.05 | N/A | N/A | $69.9M | $67M | = | | | Details |
| 2/23/17 | |
Q416 | $0.01 | -$0.01 | +$0.02 | $71.3M | $67.23M | = | | | Details |
